Pilot Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa

Condition:   Retinitis Pigmentosa Intervention:   Biological: Intravitreal autologous CD34+ cells Sponsors:   University of California, Davis;   Cures Within Reach Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials